Algenics Signs With Roquette For The Development Of An Innovative Microalgae Strain For High Value Industrial Uses

ALGENICS SAS has announced that it has signed a new cooperation contract with the ROQUETTE Group for the development of an innovative microalgae strain capable of producing high levels of a metabolite for high value industrial uses. The two-year programme is based on the use of ALGENICS’ genetic engineering platform, AlgebiosysTM, and is coupled with the signature of a licensing agreement for use of the technology. The financial terms of the contract have not been disclosed.